(Q37698437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Human nucleoside transporters: biomarkers for response to nucleoside drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Vijaya L Damaraju

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michael B Sawyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

James D Young

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carol E Cass

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

Nucleosides, Nucleotides & Nucleic Acids

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

450-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

Nucleoside transporters: molecular biology and implications for therapeutic development

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Mammalian nucleoside transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Nucleoside transport and its significance for anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The equilibrative nucleoside transporter family, SLC29

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Identification and characterization of a novel monoamine transporter in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Cladribine (2-chlorodeoxyadenosine)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

21 January 2018

Capecitabine: a review

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Identification and functional analysis of variants in the human concentrative nucleoside transporter 2, hCNT2 (SLC28A2) in Chinese, Malays and Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 cor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770903044499

10.1080/15257770903044499

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20183595%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference